EOLS – evolus, inc. (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day EOLS SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
11/5/2025
04:05 pm
eols
evolus, inc.
BEAT
5.4%
8/5/2025
04:05 pm
eols
evolus, inc.
MISS
-28.5%
5/7/2025
04:05 pm
eols
evolus, inc.
MISS
-14.2%
3/4/2025
04:05 pm
eols
evolus, inc.
MISS
-1.3%
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Top News Gainers
6/4 Form 4/A Evolus, Inc. For: Jun 03 Filed by: Alphaeon Corp 16.7%
11/7 Evolus Announces Pricing of Public Offering of Common Stock 14.3%
7/17 Form 4 Evolus, Inc. For: Jul 15 Filed by: Parschauer Karah Herdman 11.6%
5/17 Form 424B4 Evolus, Inc. 8.0%
8/8 Juvly Aesthetics Continues Its Leadership Expansion with Appointment of a Chief People Officer 6.7%
2/25 Form 10-K Evolus, Inc. For: Dec 31 6.0%
5/21 ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt 5.4%
7/16 Form 8-K Evolus, Inc. For: Jul 15 4.8%
10/15 Evolus Inc (NASDAQ: EOLS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.4%
5/31 Form 4 Evolus, Inc. For: May 31 Filed by: SILVERNAIL LAUREN P 4.2%
Top News Decliners
5/15 ALPHAEON Corporation sells 4 million shares in Evolus Inc. -11.2%
8/13 Evolus Inc (NASDAQ: EOLS) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $30.00 price target on the stock. -11.0%
3/17 Form DEF 14A Evolus, Inc. For: May 01 -10.7%
2/25 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.850 ActVsEst 0.380 - Beat -8.6%
3/27 Evolus Inc (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $31.00 to $16.00. They now have a "buy" rating on the stock. -8.0%
3/4 Evolus Provides Update on International Trade Commission (ITC) Case -7.7%
1/9 Form 8-K Evolus, Inc. For: Jan 09 -7.0%
1/10 Form 8-K Evolus, Inc. For: Jan 10 -6.8%
3/3 Evolus to Participate in Barclays 2020 Global Healthcare Conference -6.3%
8/12 Q2/2019 6/30/2019 EPS -1.370 ZacksConsensus -0.960 ActVsEst (0.410) - Miss -6.2%

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
EOLS – evolus, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EOLS
SPY
QQQ
SPX
EOLS – evolus, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EOLS SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Stock Stats
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
12/1
09:02 pm
eols
Medium
Evolus (NASDAQ:EOLS) was given a new $19.00 price target on by analysts at Mizuho.
11/27
08:01 am
eols
Low
Evolus, Inc.'s (NASDAQ:EOLS) Path To Profitability [Yahoo! Finance]
11/19
02:55 pm
eols
Low
The Dr. Randi Show Podcast, Sponsored by NewBeauty, Ranks in the Top 10% Globally for Conversations in Aesthetics, Beauty, Wellness & Medicine [Yahoo! Finance]
11/14
04:05 pm
eols
Medium
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/12
10:05 am
eols
Low
Moxie Announces Aesthetic Business Advisory Board and Scale Society Community to Shape the Next Era of Aesthetic Medicine
11/8
04:18 pm
eols
Medium
Evolus, Inc. (EOLS) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/6
10:22 am
eols
Neutral
Evolus (EOLS) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
11/5
04:05 pm
eols
Medium
Evolus Reports Third Quarter 2025 Financial Results
10/28
08:00 am
eols
Low
Evolus to Participate in 2025 Stifel Healthcare Conference
11/5/2025
04:05 pm
eols
5.4%
BEAT
8/5/2025
04:05 pm
eols
-28.5%
MISS
5/7/2025
04:05 pm
eols
-14.2%
MISS
3/4/2025
04:05 pm
eols
-1.3%
MISS
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
12/2
10:27 am
Maintains
Outperform
Outperform
Mizuho
Low
-1.4%
12/2
10:27 am
Maintains
Outperform
Outperform
Mizuho
Low
-1.4%
9/8
11:52 am
Reiterates
Buy
Buy
BTIG Research
Low
-0.8%
9/8
11:47 am
Reiterates
Buy
Buy
BTIG
Low
-0.8%
11/14
04:51 pm
eols
Low
Form SCHEDULE 13G/A Evolus, Inc. Filed by: Nantahala Capital Management, LLC
11/14
02:30 pm
eols
Low
Form SCHEDULE 13G/A Evolus, Inc. Filed by: Caligan Partners LP
11/14
01:37 pm
eols
Low
Form SCHEDULE 13G/A Evolus, Inc. Filed by: LYNCH TIMOTHY P
11/5
05:03 pm
eols
Medium
Form 10-Q Evolus, Inc. For: Sep 30
11/5
04:13 pm
eols
Medium
Form 8-K Evolus, Inc. For: Nov 05
10/9
04:57 pm
eols
Low
Form 3 Evolus, Inc. For: Sep 08 Filed by: Mitchell Tatjana
10/9
04:57 pm
eols
Low
Form 4 Evolus, Inc. For: Sep 08 Filed by: Mitchell Tatjana
9/8
08:33 am
eols
Low
Form 8-K Evolus, Inc. For: Sep 08
Show more
Top News Gainers
6/4 Form 4/A Evolus, Inc. For: Jun 03 Filed by: Alphaeon Corp 16.7%
11/7 Evolus Announces Pricing of Public Offering of Common Stock 14.3%
7/17 Form 4 Evolus, Inc. For: Jul 15 Filed by: Parschauer Karah Herdman 11.6%
5/17 Form 424B4 Evolus, Inc. 8.0%
8/8 Juvly Aesthetics Continues Its Leadership Expansion with Appointment of a Chief People Officer 6.7%
2/25 Form 10-K Evolus, Inc. For: Dec 31 6.0%
5/21 ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt 5.4%
7/16 Form 8-K Evolus, Inc. For: Jul 15 4.8%
10/15 Evolus Inc (NASDAQ: EOLS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.4%
5/31 Form 4 Evolus, Inc. For: May 31 Filed by: SILVERNAIL LAUREN P 4.2%
Top News Decliners
5/15 ALPHAEON Corporation sells 4 million shares in Evolus Inc. -11.2%
8/13 Evolus Inc (NASDAQ: EOLS) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $30.00 price target on the stock. -11.0%
3/17 Form DEF 14A Evolus, Inc. For: May 01 -10.7%
2/25 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.850 ActVsEst 0.380 - Beat -8.6%
3/27 Evolus Inc (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $31.00 to $16.00. They now have a "buy" rating on the stock. -8.0%
3/4 Evolus Provides Update on International Trade Commission (ITC) Case -7.7%
1/9 Form 8-K Evolus, Inc. For: Jan 09 -7.0%
1/10 Form 8-K Evolus, Inc. For: Jan 10 -6.8%
3/3 Evolus to Participate in Barclays 2020 Global Healthcare Conference -6.3%
8/12 Q2/2019 6/30/2019 EPS -1.370 ZacksConsensus -0.960 ActVsEst (0.410) - Miss -6.2%